| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.009 |